G173D (p.Gly173Asp) variant of ACE2 (Angiotensin-converting enzyme 2)
G173D (p.Gly173Asp) in ACE2 (Angiotensin-converting enzyme 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.59 / 1. The record also includes structural context.
G173D (p.Gly173Asp) variant details
- p.Gly173Asp
- rs865852627
- NCI-TCGA Cosmic COSV1043
- cosmic curated COSV10438
- Ensembl rs865852627
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.592
- AlphaMissense 0.94
- MetaLR 0.45
- MetaSVM 0.22
- PolyPhen-2 1.00
- SIFT 0.00
- MutPred 0.92
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available